Source – The Wall Street Journal
United Healthcare has been dishing a lot of heat this year for treatments that are unproven and/or that they deem aren’t medically necessary for any indication. United Healthcare has said that they won’t reimburse patients who have used amniotic tissue products made by MiMedx Group because there is insufficient clinical evidence to conclude that these skin substitutes help improved their health. The MiMedx group said that the United health care has not covered MiMedx products, so there shouldn’t be any change in coverage but since being denied by huge insurance companies, MiMedx has been going down.
MiMedx prospered in 2011 when amniotic skin substitutes were used for woman who had given birth by cesarean section. It was said that by using this skin substitute, the woman would heal more quickly. This founded them great success but lately, they haven’t been doing as well. Once Wall Street Journal announced all of the backlash they’ve been getting by insurance agencies, their shares have been going down. MiMedx shares that peaked to 18 dollars earlier this year has now gone down to 4$. With information getting out that big healthcare insurance won’t pay for patients who use amniotic tissue products and that there is allegations being made my former employees, MiMedx seems to have a lot of work to do to get back to where they originally were
Gables Medical Review will help determine if your denied claim can be paid by the carrier. Their goal is to make sure that the insurance company pays what they’re supposed to so that what happened to Kate Weissman and millions of others does not happen to you.